Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ichor Life Sciences is a vertically integrated, US-based contract research organization (CRO) with full pre-clinical R&D capabilities. The company focuses on fundamental mechanisms of aging and drug discovery for age-related diseases, offering services from target identification through in vivo studies. Ichor has a strong publication record, a PhD training program, and operates multiple research facilities in Syracuse, NY. The company has not reported clinical-stage assets but supports programs from ideation to IND-enabling studies for both internal and external clients. Subsidiaries and portfolio companies are advancing programs in mitochondrial dysfunction, immunosenescence, protein crosslinks, and recombinant enzyme therapies for eye disease[1][2][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ichor Life Sciences.